AI-generated summary
The authors systematically reviewed the literature on laser and other light therapies for oral mucositis in cancer patients and assigned evidence levels to each intervention. They report a recommendation for low-level laser at 650 nm for preventing mucositis in adults receiving stem cell transplantation, and a suggestion for laser around 632.8 nm in head and neck radiotherapy patients. Evidence was insufficient to make guidelines for other populations and light sources, and the authors call for more well-designed research.
- Who or what was studied
- Adult cancer patients with oral mucositis, including those receiving hematopoietic stem cell transplantation or radiotherapy for head and neck cancer
- Wavelengths
- 650, 632 nm
- Limits stated in the abstract
- The abstract states that evidence for other populations and light sources was insufficient and that additional well-designed research is needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 650 nm
- Power
- 40 mW
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Oral mucositis, Systematic review, Wavelength, Dose, Low-level laser therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.